학술논문

Tuberculosis: from genome to vaccine
Document Type
Academic Journal
Source
Expert Review of Vaccines. August 2005, Vol. 4 Issue 4, p541, 11 p.
Subject
Genomics
Tuberculosis vaccines
Antitubercular agents
Genomes
Tuberculosis -- Genetic aspects
Anopheles
Health
Genetic aspects
Language
English
ISSN
1476-0584
Abstract
The availability of mycobacterial genome sequences has paved the way to identifying potential tuberculosis vaccine candidates in order to replace the currently used bacillus Calmette-Guérin (BCG) vaccines that show variable protective efficacy in adults. Genomics provides the basis for bioinformatic, transcriptomic and proteomic analysis, increases screening efficiency and enables valuable information concerning the biology and virulence of the mycobacterial species to be extracted by comparative genomics. Although in silico results must be confirmed in vitro and in vivo, bioinformatic analysis of the genomes is highlighting candidates for testing. For designing subunit vaccines, attenuated or improved recombinant whole-cell live vaccines, information from the genomes of the human host and pathogenic mycobacterial species is of great help.
Author(s): Marien I de Jonge [sup.1] , Roland Brosch [sup.CACBJBGJ] , Priscille Brodin [sup.CACJJGBB] , Caroline Demangel [sup.CACBAHJH] , Stewart T Cole [sup.[[dagger]]] [sup.CACFAEGJ] Keywords: bacillus Calmette-Guérin (BCG); comparative genomics; [...]